At initiation of parenteral prostacyclin therapy, 62% of patients had intermediate-high COMPERA 2.0 risk status, whereas at ...

In COPD, patients with abnormally high exertional breathlessness on CPET are unlikely to be identified via standard symptom ...

Increased CVD incidence is observed in patients with vs without TB, particularly within months of TB diagnosis, regardless of ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

The use of influenza testing at hospital emergency department visits increased from 2013 to 2022 in the United States.

The US FDA wants to redefine the meaning of healthy food, issuing a new rule that changes the way food companies can claim ...

The US FDA re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication ...

Credit: Shutterstock Images A pulmonologist sued for medical malpractice sought to have the case dismissed on the grounds that expert testimony supporting the case’s validity was insufficient.

A Prescription Drug User Fee Act target date of June 10, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for ...

Patients with COPD who switched to LABA/LAMA/ICS vs LABA/LAMA after previously using LABA/ICS had a higher risk for severe pneumonia and death.

Lower pulmonary microvascular blood volume (PMBV) is associated with greater percent emphysema in those with a diffuse emphysema subtype.